MUMBAI, India, June 22 -- Intellectual Property India has published a patent application (202641069316 A) filed by Aurangjeb Khan on June 02, 2026, for Hypo Sense (iot-Based Wearable Nocturnal Hypoglycemia Early Warning System).
Inventors include Aurangjeb Khan; Dr. Ashok Kumar Ta; Dr. Densy John Vadakkan; Sai Niranjan S; and Cmr University.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: HypoSense is a low-cost, IoT-based wearable system designed to detect nocturnal hypoglycemia — dangerously low blood sugar episodes that occur in diabetic patients during sleep — and immediately alert family members via Telegram. The system addresses a life-threatening gap in affordable diabetic care for the 101 million diabetics in India, 95% of whom cannot afford professional Continuous Glucose Monitors (CGMs) that cost Rs. 90,000 per year. The device uses a multi-symptom sensor fusion approach — simultaneously monitoring heart rate, skin temperature, and sweat conductance — and triggers an alert only when two or more symptoms cross their clinical thresholds simultaneously. This prevents false alarms while ensuring genuine episodes are never missed.
Disclaimer: Curated by HT Syndication.
